Ausgabe 3/2014
Inhalt (9 Artikel)
A Vision for Drug Discovery and Development: Novel Targets and Multilateral Partnerships
Roger S. McIntyre
Pathophysiological and Pharmacological Rationale for the Use of Exenatide Once Weekly in Patients with Type 2 Diabetes
Samuel S. Grossman
Zonisamide as a Treatment for Partial Epileptic Seizures: A Systematic Review
Joanna H. Cox, Stefano Seri, Andrea E. Cavanna
Incorporating Incretin-Based Therapies into Clinical Practice for Patients with Type 2 Diabetes
Joseph M. Tibaldi
Impact of Dronedarone Treatment on Healthcare Resource Utilization in Patients with Atrial Fibrillation/Flutter
Michael H. Kim, Jay Lin, Mehul Jhaveri, Andrew Koren
Efficacy and Tolerability of Fixed-Dose Combination of Perindopril/Indapamide in Type 2 Diabetes Mellitus: PICASSO Trial
Csaba Farsang
Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Luseogliflozin Dosing in Healthy Japanese Males: A Randomized, Single-Blind, Placebo-Controlled Trial
Takashi Sasaki, Yutaka Seino, Atsushi Fukatsu, Soichi Sakai, Yoshishige Samukawa
Efficacy and Safety of Vitex agnus-castus Extract for Treatment of Premenstrual Syndrome in Japanese Patients: A Prospective, Open-label Study
Mikio Momoeda, Hidetaka Sasaki, Eiko Tagashira, Masayuki Ogishima, Yuichi Takano, Kazunori Ochiai